- Associated Press - Wednesday, April 1, 2015

FOREST, Va. (AP) - Teva Pharmaceutical Industries Ltd. will supply the U.S. military with a Virginia-made vaccine to combat the spread of infectious respiratory disease in basic training camps.

Media outlets report the Army announced the $170 million contract Monday between Jerusalem-based Teva and the U.S. Defense Department.

The adenovirus vaccine is manufactured at Teva’s plant in Forest.

Under the five-year contract, the company anticipates the military’s nine basic training camps will need about 250,000 vaccine doses per year.


Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide